Article thumbnail

Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema - a long-term analysis from a Swiss perspective

By Patricia R Blank, Armin A Blank and Thomas D Szucs
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2908557
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2008). [Alitretinoin: a new treatment option for chronic refractory hand eczema]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
  2. (2008). [Chronic hand eczema: epidemiology and therapeutic evidence]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
  3. (2009). Alitretinoin for the treatment of severe chronic hand eczema (This guidance was developed using the single technology appraisal process). NICE technology appraisal guidance
  4. (2001). BR: What is the cost of atopic dermatitis in preschool children? The British journal of dermatology
  5. (2007). Coenraads PJ: Management of chronic hand eczema. Contact dermatitis
  6. (2006). Cost-effectiveness of eplerenone in patients with left ventricular dysfunction after myocardial infarction--an analysis of the EPHESUS study from a Swiss perspective. Cardiovasc Drugs Ther
  7. (2007). Costeffectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial. Ann Oncol
  8. Costs incurred for recognized occupational diseases (1997-2006). Central Office for Statistics in Accident Insurance (SSUV).
  9. (2004). Diepgen TL: [Quality of life of patients with occupationally-induced hand eczema]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
  10. (1990). Epidemiology of hand eczema in an industrial city. Acta Derm Venereol Suppl (Stockh)
  11. (2006). Etanercept and efalizumab for the treatment of psoriasis: a systematic review. Health technology assessment (Winchester,
  12. (2002). F: The cost of atopic dermatitis in the Netherlands: an international comparison. The British journal of dermatology
  13. for Health and Clinical Excellence - Guide to the methods of technology appraisal [http://www.nice.org.uk/]
  14. (2008). Future drug prices and cost-effectiveness analyses. PharmacoEconomics
  15. (2004). HC: Overview of studies of treatments for hand eczema-the EDEN hand eczema survey. The British journal of dermatology
  16. (2002). Held E: Skin protection programmes. Contact dermatitis
  17. (2008). Institute for Health and Clinical Excellence: Adalimumab for the treatment of adults with psoriasis (guidance developed using the single technology appraisal process).
  18. (2008). Institute for Health and Clinical Excellence: full guidance on adalimumab for the treatment of psoriasis TA146.
  19. (1996). JA: The cost of atopic eczema. The British journal of dermatology
  20. (1983). Jarvholm B: Hand eczema in Swedish adults - changes in prevalence between
  21. (2004). Meding B: Health-related quality of life and hand eczema--a comparison of two instruments, including factor analysis.
  22. (2002). NM: Prognosis and work absence due to occupational contact dermatitis. Contact dermatitis
  23. (1973). Occupational skin diseases, United States. Results from the Bureau of Labor Statistics Annual Survey of Occupational Injuries and Illnesses,
  24. (1996). Occupational skin diseases. Contact dermatitis
  25. (2003). Occupational skin-disease data in Europe. International archives of occupational and environmental health
  26. (2004). Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. Archives of dermatology
  27. (2001). PE: Social impact of atopic dermatitis. Medicine and health,
  28. (2002). Pharmacoeconomics of drug therapy for atopic dermatitis. Expert opinion on pharmacotherapy
  29. (2001). Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis. The British journal of dermatology
  30. (2009). Quality of Life in chronic hand eczema as measured by the Dermatology Life Quality Index. ISPOR
  31. (2007). Re-treatment study of alitretinoin (9-cisretinoic acid) in severe chronic hand eczema refractory to topical treatment (Poster 280). EADV
  32. Recognized occupational diseases (1997-2006). Central Office for Statistics in Accident Insurance (SSUV).
  33. (2008). S: Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland. Curr Med Res Opin
  34. (2008). T: [New and rarley used treatment options for refractory hand eczema: local UVA-1 phototherapy, retinoids, calcineurin inhibitors]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
  35. (2005). T: Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema. The British journal of dermatology
  36. (2003). Table 3.2.1: Occupational cases according to legal regulation
  37. (2009). TC: Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. The British journal of dermatology
  38. (2001). The public health approach to the burden of common skin diseases in the community. The Journal of dermatology
  39. (1996). The role of costeffectiveness analysis in health and medicine.
  40. (2010). This article is available from: http://www.biomedcentral.com/1471-5945/10/4 ©
  41. (2006). TL: Educational and dermatological aspects of secondary individual prevention in healthcare workers. Contact dermatitis
  42. (2002). Werden Inzidenz und Prävalenz berufsbedingter Hauterkrankungen unterschätzt? Arbeitsmed Sozialmed Umweltmed
  43. (2010). Wolverton SE: Recent trends in systemic psoriasis treatment costs. Archives of dermatology